Drugs / PSN821
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01386099 | May 2011 → Jan 2012 | type 2 diabetes mellitus | Prosidion Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PSN821 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01386099 ↗ |